Loomis, Sayles & Company’s Royalty Pharma RPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-627
| Closed | -$18K | – | 919 |
|
|
2023
Q4 | $18K | Buy |
627
+326
| +108% | +$9.36K | ﹤0.01% | 697 |
|
|
2023
Q3 | $8K | Hold |
301
| – | – | ﹤0.01% | 848 |
|
|
2023
Q2 | $9K | Sell |
301
-34
| -10% | -$1.02K | ﹤0.01% | 728 |
|
|
2023
Q1 | $12K | Buy |
+335
| New | +$12K | ﹤0.01% | 806 |
|
|
2022
Q4 | – | Sell |
-38
| Closed | -$2K | – | 964 |
|
|
2022
Q3 | $2K | Sell |
38
-33
| -46% | -$1.74K | ﹤0.01% | 840 |
|
|
2022
Q2 | $3K | Hold |
71
| – | – | ﹤0.01% | 782 |
|
|
2022
Q1 | $3K | Buy |
+71
| New | +$3K | ﹤0.01% | 895 |
|
|
2021
Q4 | – | Sell |
-228
| Closed | -$8K | – | 881 |
|
|
2021
Q3 | $8K | Buy |
+228
| New | +$8K | ﹤0.01% | 869 |
|